Biomedical subjects

Xiangliang Yang

Publications and source records attributed to Xiangliang Yang.

21 records · Page 2Linked to original sources

PubMed2003

[Study on effects of Erigeron breviscapus extract on anticoagulation].

OBJECTIVE: To study the effect of Erigeron breviscapus extract on anticoagulation. METHOD: Coagulation time (CT), prothrombin time (PT), platelet factor III (PF3) and euglobulin lysis time (ELT) have been used to evaluate the anticoagulation activities of Erigeron breviscapus extract. RESULT: Erigeron breviscapus extract significantly delayed CT and PT, inhibited the activity of PF3, and decreased ELT. CONCLUSION: Erigeron breviscapus extract plays an role in anticoagulation by inhibiting PF3 and prothrombin V. It can also enhance the activity of fibrimolysis.

Animals↗

PubMed2002

Synthesis of novel cyclomaltoheptaose (beta-cyclodextrin) derivatives containing the Ebselen key moiety of benzoisoselenazolone.

A series of five novel cyclomaltoheptaose (beta-cyclodextrin) derivatives containing benzoisoselenazolone groups have been synthesized as glutathione peroxidase mimics.

Carbohydrate Conformation↗

PubMed2002

[Study on effects of scutellarin on scavenging reactive oxygen].

OBJECTIVE: To study the antioxidative effects and its mechanism of scutellarin. METHODS: Scavenging effects of scutellarin on hydroxyl radical (OH.) produced from 0-phenathroline-ascorbic acid system, super oxide anion radical (O2-.) produced from xanthine-xanthine oxidase-luminol system and hydrogen peroxide was studied by a chemiluminescence assay. RESULTS: Scutellarin has a significant effect on scavenging hydroxyl radicals, super oxide anion radicals, hydrogen peroxide, their IC50 are 66 micrograms/ml, 1.3 micrograms/ml and 1.6 micrograms/ml respectively. CONCLUSION: Scutellarin is an efficiency antioxidant.

Apigenin↗